Analysts Set Expectations for RIGL FY2026 Earnings
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Rigel Pharmaceuticals in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company will post earnings of $1.05 per share for the year. Cantor Fitzgerald […]
